Risperidone in Children With Disruptive Behavior Disorders and Subaverage Intelligence: A 1-Year, Open-Label Study of 504 Patients
- 1 January 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 44 (1) , 64-72
- https://doi.org/10.1097/01.chi.0000145805.24274.09
Abstract
No abstract availableKeywords
Funding Information
- Johnson and Johnson Pharmaceutical Research and Development
This publication has 19 references indexed in Scilit:
- Growth and Sexual Maturation During Long-Term Treatment With RisperidoneAmerican Journal of Psychiatry, 2004
- Long-Term, Open-Label Study of Risperidone in Children With Severe Disruptive Behaviors and Below-Average IQAmerican Journal of Psychiatry, 2004
- Prolactin Levels During Long-Term Risperidone Treatment in Children and AdolescentsThe Journal of Clinical Psychiatry, 2003
- Double-Blind, Placebo-Controlled Study of Risperidone for the Treatment of Disruptive Behaviors in Children With Subaverage IntelligenceAmerican Journal of Psychiatry, 2002
- A Randomized Controlled Trial of Risperidone in the Treatment of Aggression in Hospitalized Adolescents With Subaverage Cognitive AbilitiesThe Journal of Clinical Psychiatry, 2001
- A Double-Blind Pilot Study of Risperidone in the Treatment of Conduct DisorderJournal of the American Academy of Child & Adolescent Psychiatry, 2000
- The Nisonger CBRF: A child behavior rating form for children with developmental disabilitiesResearch in Developmental Disabilities, 1996
- Long-Term Outcome of Disruptive DisordersChild and Adolescent Psychiatric Clinics of North America, 1994
- Behavioral Efficacy of Haloperidol and Lithium CarbonateArchives of General Psychiatry, 1984
- Physical growth: National Center for Health Statistics percentilesThe American Journal of Clinical Nutrition, 1979